Skip to content

Clinical trials

Phase 3 Arthritis, Rheumatoid trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 3 Country / region: India Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20082
20093
20104
20114
20124
20131
20164
20171
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Pfizer4
AstraZeneca3
GlaxoSmithKline3
Biocad2
Bristol-Myers Squibb2
Gilead Sciences2
Novartis Pharmaceuticals2
Alfasigma S.p.A.1
All India Institute of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid29
Autoimmune Diseases1
Connective Tissue Diseases1
Fibrosis1
Joint Diseases1
Lung Diseases, Interstitial1
Pulmonary Fibrosis1
Rheumatic Diseases1
Sarcoidosis1
Scleroderma, Diffuse1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.